Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 428,564 | 255,336 | N/A | N/A |
| Depreciation Amortization | 20,836 | 13,875 | N/A | N/A |
| Accounts receivable | -248,534 | -121,675 | N/A | N/A |
| Other Working Capital | -182,578 | -100,485 | N/A | N/A |
| Other Operating Activity | 180,480 | 113,690 | 0 | 0 |
| Operating Cash Flow | $198,767 | $160,742 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -280,613 | -205,950 | N/A | N/A |
| PPE Investments | -11,842 | -11,356 | N/A | N/A |
| Purchase Sale Intangibles | -4,797 | -64,259 | N/A | N/A |
| Other Investing Activity | -4,797 | -64,259 | 0 | 0 |
| Investing Cash Flow | $-297,252 | $-281,564 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 590,306 | 11,923 | N/A | N/A |
| Common Stock Repurchased | N/A | -23,154 | N/A | N/A |
| Other Financing Activity | -41,672 | 0 | 0 | 0 |
| Financing Cash Flow | $548,634 | $-11,231 | $N/A | $N/A |
| Exchange Rate Effect | 2,398 | 3,014 | N/A | N/A |
| Beginning Cash Position | 79,897 | 213,451 | N/A | N/A |
| End Cash Position | 532,445 | 84,413 | N/A | N/A |
| Net Cash Flow | $452,548 | $-129,039 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 198,767 | 160,742 | N/A | N/A |
| Free Cash Flow | 198,767 | 160,742 | 0 | 0 |